BNY Mellon Global Real Return Fund - Class A
DRRAX
NASDAQ
| Weiss Ratings | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Reward Grade | D+ | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Company Info | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | BNY Mellon | |||
| Manager/Tenure (Years) | Aron Pataki (10), Nick Pope (1), Trevor Holder (0) | |||
| Website | http://www.bny.com/investments | |||
| Fund Information | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | BNY Mellon Global Real Return Fund - Class A | |||
| Category | Tactical Allocation | |||
| Sub-Category | Flexible Allocation | |||
| Prospectus Objective | Growth and Income | |||
| Inception Date | May 12, 2010 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 1,000.00 | |||
| Minimum Subsequent Investment | 100.00 | |||
| Front End Fee | 0.06 | |||
| Back End Fee | -- | |||
| Dividends and Shares | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 3.36% | |||
| Dividend | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 2.00% | |||
| Asset Allocation | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 1.67% | |||
| Stock | 36.10% | |||
| U.S. Stock | 22.77% | |||
| Non-U.S. Stock | 13.33% | |||
| Bond | 47.37% | |||
| U.S. Bond | 16.67% | |||
| Non-U.S. Bond | 30.70% | |||
| Preferred | 0.26% | |||
| Convertible | 0.00% | |||
| Other Net | 14.60% | |||
| Price History | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.66% | |||
| 30-Day Total Return | -0.66% | |||
| 60-Day Total Return | 0.79% | |||
| 90-Day Total Return | 2.06% | |||
| Year to Date Total Return | 7.61% | |||
| 1-Year Total Return | 10.80% | |||
| 2-Year Total Return | 20.28% | |||
| 3-Year Total Return | 38.00% | |||
| 5-Year Total Return | 26.05% | |||
| Price | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $17.80 | |||
| 1-Month Low NAV | $17.80 | |||
| 1-Month High NAV | $18.09 | |||
| 52-Week Low NAV | $16.48 | |||
| 52-Week Low NAV (Date) | Oct 10, 2025 | |||
| 52-Week High NAV | $18.16 | |||
| 52-Week High Price (Date) | Aug 25, 2026 | |||
| Beta / Standard Deviation | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.00 | |||
| Standard Deviation | 6.74 | |||
| Balance Sheet | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 858.11M | |||
| Operating Ratios | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.19% | |||
| Turnover Ratio | 119.04% | |||
| Performance | DRRAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 20.56% | |||
| Last Bear Market Total Return | -2.90% | |||